XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 28, 2025
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the six month period ended June 28, 2025 was as follows:

 

   Shares   Weighted Average
Grant Fair Value
   Fair
Value
   Intrinsic Value 
Non-vested at December 28, 2024   4,833,611   $1.19   $5,757,391   $6,718,720 
Granted   2,797,864    1.37   $3,833,074    - 
Forfeited   (639,376)   1.89   $(1,208,421)   - 
Vested   (577,845)   1.61   $(930,330)   - 
Non-vested at June 28, 2025   6,414,254   $1.16   $7,451,714   $9,942,094 
Expected to vest   6,414,254                
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock and stock options awards for the three and six months ended June 28, 2025 and June 29, 2024 (no tax benefits were recognized):

 

   Three Months
Ended
   Three Months
Ended
   Six Months
Ended
   Six Months
Ended
 
   June 28, 2025   June 29, 2024   June 28, 2025   June 29, 2024 
Cost of product revenues  $86,569   $268,318   $226,006   $488,924 
Research and development   124,345    117,086    242,065    260,909 
Selling, general and administrative   536,803    291,014    1,054,038    661,513 
Total  $747,717   $676,418   $1,522,109   $1,411,346 
SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS

 

   Three Months
Ended
   Six months
ended
 
   June 28, 2025   June 28, 2025 
Average risk-free interest rate   4.54%   4.54%
Expected dividend yield   None    None 
Expected life (average, in years)   8.00    8.00 
Expected volatility   85%   85%
Weighted average exercise price  $1.76   $1.76 
Weighted average fair value  $1.16   $1.16 
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of stock option activity for the period ended June 28, 2025 is as follows:

 

   Number of Options   Weighted Average Exercise Price   Intrinsic Value 
Outstanding as of December 28, 2024      $   $ 
Granted   591,366   $1.76      
Outstanding as of June 28, 2025   591,366   $1.76   $ 
Options exercisable as of December 28, 2024      $   $ 
Options exercisable as of June 28, 2025   591,366   $1.76   $